Lu Xiaoxi; Wang Zhi; Ma Zhigui; Gao Ju; Zhu Yiping
【Abstract】 Objective To analysis the cause of primary graft failure of unrelated cord blood transplantation with high-dose of CD34+ cells in treatment of acute myelocytic leukemia(AML)/myelodysplastic syndrome (MDS). Methods A 4-year-old girl was diagnosed AML/MDS at the Department of Pediatric Hematology and Oncology of West China Second University Hospital of Sichuan University. She presented completely remission after induction and consolidation chemotherapy. She received unrelated partially human leukocyte antigen(HLA)-mismatched cord blood transplantation. We investigated the treatment outcomes of UCBT and associated complications. Results The patient suffered primary graft failure and then received secondary haploidentical hematopoietic stem cell transplantation(HSCT) from her mother. However, she suffered fatal multiresistant Acinetobacter spp septicemia. She died due to respiratory failure at 7 d post the second transplantation. Conclusions In this case, hematopoietic stem cell with high dose of CD34+ cells could not overcome the risk of primary graft failure and HLA disparity. The patient’s primary graft failure was associated with platelet transfusion refractoriness and potent immunologic dysfunction, especially the anti-HLA donor specific antibodies before unrelated cord blood transplantation.
作者简介: 通讯作者：朱易萍，Email: firstname.lastname@example.org
电话：020-38736410 传真：020-85253160 Email:email@example.com